Demonstrates the feasibility of using the HeartWare third-generation continuous flow pump for biventricular support in a patient with a small chest size.
Supports feasibility of HeartWare biventricular support in small-chest patients; leaves open need for larger prospective validation.
A long-term mechanical biventricular support by HeartWare HVAS third-generation continuous flow pump (HeartWare, Inc, Miramar, FL, USA) was implanted in a Korean patient with a small chest size for treatment of a refractory end-stage heart failure due to an idiopathic dilative cardiomyopathy. We report our experience with a single patient and the early mid-term follow-up results with such a mechanical ventricular support.
No takes yet. Share an insight, caveat, or question.
Loforte et al. (2010) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: